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Abstract
Health Issue: Cardiovascular disease (CVD) is the leading cause of death in Canadian women and
men. In general, women present with a wider range of symptoms, are more likely to delay seeking
medial care and are less likely to be investigated and treated with evidence-based medications,
angioplasty or coronary artery bypass graft than men.
Key Findings: In 1998, 78,964 Canadians died from CVD, almost half (39,197) were women.
Acute myocardial infarction, which increases significantly after menopause, was the leading cause
of death among women.
Cardiovascular disease accounted for 21% of all hospital admissions for Canadian women over age
50 in 1999. Admissions to hospital for ischemic heart disease were more frequent for men, but the
mean length of hospital stay was longer for women.
Mean blood pressure increases with age in both men and women. After age 65, however, high
blood pressure is more common among Canadian women. More than one-third of postmenopausal
Canadian women have hypertension.
Diabetes increases the mortality and morbidity associated with CVD in women more than it does
in men. Depression also contributes to the incidence and recovery from CVD, particularly for
women who experience twice the rate of depression as men.
Data Gaps and Recommendations: CVD needs to be recognized as a woman's health issue
given Canadian mortality projections (particularly heart failure). Health professionals should be
trained to screen, track, and address CVD risk factors among women, including hypertension,
elevated lipid levels, smoking, physical inactivity, depression, diabetes and low socio-economic
status.
Background
Cardiovascular disease (CVD) is a leading cause of death
in Canadian women and men[1]. In general, the onset of
CVD is approximately 10 years later in women than in
men; women present with a wider range of symptoms[2];
and women are less likely to seek medical care and are less
likely than men to be investigated and treated for CVD
with specific medications, angioplasty or coronary artery
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bypass graft [3-7]. Sex differences have also been
described in CVD risk factors, including cigarette smok-
ing, depression, low income, elevated serum lipids, hyper-
tension, obesity and lack of physical activity[8,9].
Vulnerable subpopulations include Aboriginal
women[10,11], South Asian women[12] and women with
diabetes mellitus[13].
Methods
The results of searches of MEDLINE, PsycINFO and Social
Science Abstracts published in English from 1990 to 2002
were used to select the articles included in the literature
review. Prevalence data were available through self-report
in the National Population Health Survey (NPHS) 1998–
1999 cycle[14] and the 2000 Canadian Community
Health Survey (CCHS)[15]. Vital statistics databases were
analyzed to determine mortality by sex and province[16].
Population rates of hospital admission for CVD by sex
and province were obtained with the use of databases
from the Canadian Institute for Health Information
(CIHI)[1]. Data from the NPHS and the CCHS were ana-
lyzed to determine the associations of risk factors such as
cigarette smoking, leisure-time activity and overweight
with self-reported heart disease, as well as to examine vul-
nerable subgroups according to income, education, eth-
nicity/culture, social support, marital status and family
structure, by sex and province. The results of the Canadian
Heart Health Survey[17] were examined to ascertain the
prevalence of high serum cholesterol levels and hyperten-
sion, and people's knowledge of the major causes of CVD.
International comparisons were obtained from Organiza-




The Canadian prevalence of CVD is available only
through self-reported data from the NPHS or CCHS.
When asked if they had CVD, 3.9% of men and 3.5% of
women responded affirmatively, the highest proportion
being reported by males in the Atlantic provinces[14].
Although the mortality rate for CVD, particularly ischemic
heart disease (IHD), is declining, it is unclear whether the
incidence is decreasing as well or the decline in mortality
simply reflects increased survival[19].
Mortality Rate
In 1998, there were 78,964 deaths attributable to CVD in
Canada, with generally equivalent numbers in men
(39,767) and women (39,197)[15]. Acute myocardial inf-
arction (AMI), incidence of which in women increases sig-
nificantly after menopause and continues to increase with
advanced age, was the overall leading cause of death
among women.
Canadian mortality counts for IHD by sex are presented in
Figure 1. Regional differences in mortality are more nota-
ble for AMI and IHD than for cerebrovascular disease
(CBVD). In 1997, rates of mortality from IHD among
both men and women were highest in Newfoundland and
Labrador; among men they were lowest in Prince Edward
Island, and among women they were lowest in British
Columbia.
With regard to trends over time, mortality rates declined
by half from 1969 to 1997[19]. There is still uncertainty
with regard to the causes of this decline, but it is suspected
that the reduced incidence is partially explained by
declines in risk factors as well as a reduction in case-fatal-
ity due to treatment advances. Over the lifespan, Cana-
dian CVD/CBVD mortality rates increase substantially
with age, and male rates are considerably higher than
female rates for AMI and IHD. Rates of CBVD are similar
among men and women until age 55, after which men
have increased mortality until age 85, when mortality
rates among women become higher.
Morbidity Rate/Hospitalization
Data from the Hospital Morbidity Database of CIHI dem-
onstrate that CVD is the leading cause of hospital admis-
sions for men and women (excluding pregnancy and
childbirth)[1]. CVD accounted for 21% of all hospital
admissions of Canadian women over the age of 50 in
1999, and rates among older women were higher. Admis-
sions to hospital for IHD were more frequent for men
than for women, but the mean length of hospital stay for
women surpassed that for men. Figure 2 presents hospital-
ization rates for IHD among women by age and province.
Male rates increased consistently with age, but there was a
10-year delay in AMI among women, purportedly due to
Ischemic Heart Disease Mortality in Canada, 1979–1998 Figure 1
Ischemic Heart Disease Mortality in Canada, 1979–
1998 Source: Statistics Canada. Vital Statistics, 1999.BMC Women's Health 2004, 4:S15 http://www.biomedcentral.com/1472-6874/4/S1/S15
Page 3 of 9
(page number not for citation purposes)
the protective effects of estrogen. The decline in morbidity
is not as strong as the decline in mortality across time.
With regard to provincial variation, Newfoundland and
Labrador, Nova Scotia and New Brunswick figureed par-
ticularly high rates of IHD.
International Comparisons
CVD is the leading cause of death worldwide, but rates
vary considerably between countries. In countries with
established market economies, CVD and CBVD still con-
tribute to approximately half of all deaths in spite of
declines in mortality rates over the past 30 years[20].
Overall, CVD mortality rates are about twice as high
among men as women, but in many countries the actual
number of deaths from CVD among women is similar to
that among men because of their longer life expectancy.
Figure 3 displays the IHD mortality rates from 1960 to
1999 for selected countries per 100,000 females[18]. In
the 1960s, the highest mortality rates for AMI among
women occurred in Australia, New Zealand, Ireland and
the United Kingdom (U.K.), while the lowest rates
occurred in Japan and Mediterranean countries. By the
late 1990s, Canada continued to enjoy lower rates than
the United States and the U.K., but rates were considerably




High blood pressure is an independent risk factor for CVD
in women. Mean blood pressure increases with age in
both women and men, although after age 65 high blood
pressure is more common in Canadian women than
Canadian men[21]. Over one-third of post-menopausal
Canadian women have hypertension. Women tend to be
more aware of the problem than are men and, if the con-
dition is treated, are more likely to have it under control
(see Figure 4).
Lipid Profile
High blood cholesterol in women is a major risk factor for
CVD, and this is amplified by smoking and hypertension.
The prevalence of elevated total lipids in women increases
rapidly after menopause, such that by age 55 women have
higher levels than men (see Figure 5)[24]. Although high
total cholesterol in women does not seem to be as great a
risk as it is in men, the combination of low levels of high-
density lipoprotein (HDL) and elevated triglycerides
increases women's risk of death from CVD tenfold. Forty-
three percent of Canadian women aged 18 to 74 have a
total blood cholesterol above the recommended thresh-
old of 5.2 mmol/L[25]; 32% of women have elevated low-
density lipoprotein levels (> 3.4 mmol/L); and 4% of
women have low HDL levels (< 0.9 mmol/L).
Diabetes Mellitus
Diabetes mellitus (DM) increases rates of mortality and
morbidity from CVD more in women than in men and
eliminates the advantage for women in all atherosclerotic
disease outcomes except stroke [26-29]. Diabetic women
are significantly more likely than diabetic men or non-
diabetic women to have coronary events. DM is often
associated with obesity, a sedentary lifestyle and lower
socio-economic status (SES)[30].
Depression
Depression also contributes to the incidence of and
poorer recovery from CVD [31-36], particularly for
women, who experience twice the rate of depression as
men[37]. Beaudet[38] showed that Canadians aged 55 to
74 who had had a depressive episode in the previous 12
months were nearly three times as likely to have CVD
within the following four years as people who had not
experienced any depressive episode (odds ratio [OR] =
2.7, 95% confidence intervals [CI] 1.01–7.04). Frasure-
Smith et al[39]. analyzed the impact of gender and depres-
sion after AMI in a Canadian sample and found that 8.3%
of the depressed women died of cardiac causes in contrast
to 2.7% of the non-depressed. Depression during hospi-
talization was found to have a significant impact on long-
term mortality, with the increased risk being largely
independent of CVD severity. Patients of both sexes who




According to self-reported data, Canadian women and
men with CVD tend to have annual income levels in the
Hospitalization Rates for IHD Among Women by Province  and Age, 1994–1998 Figure 2
Hospitalization Rates for IHD Among Women by 
Province and Age, 1994–1998 Source: Canadian Institute 
for Health Information.BMC Women's Health 2004, 4:S15 http://www.biomedcentral.com/1472-6874/4/S1/S15
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International Comparisons: IHD Standardized Mortality Rates Among Females, Selected Countries, 1960–1999 Figure 3
International Comparisons: IHD Standardized Mortality Rates Among Females, Selected Countries, 1960–
1999 Adapted from: OECD Health Data 2001[18]. Copyright OECD.
Proportion of Canadians 55 and Older Who Were Aware of  TheirHypertension[22] Figure 4
Proportion of Canadians 55 and Older Who Were Aware of 
TheirHypertension[22]
Proportion of Canadians 55 and Older With Hypertension  and Elevated Blood Lipid Level** Figure 5
Proportion of Canadians 55 and Older With Hyper-
tension and Elevated Blood Lipid Level** Based on 
Heart Health Survey Data 1986–1992[23]BMC Women's Health 2004, 4:S15 http://www.biomedcentral.com/1472-6874/4/S1/S15
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range of $5,000 to $30,000[14]. Moreover, most Canadi-
ans with self-reported CVD have less than secondary edu-
cation[14], and those with less education are more likely
to show early stage atherosclerosis for any given age
group[40]. Socio-economic determinants act in part
through an increased prevalence of risk factors, but they
also have an independent effect that may be mediated
through social isolation, coping styles, health behaviour,
job strain or stress, and anger or hostility[41,42].
Ethnicity/Culture
Approximately 1 in 5 Canadians is a first-generation
immigrant. In addition to genetic factors, immigrants
tend to bring with them cultural habits (e.g. food choices,
smoking behaviour) that influence their risk of develop-
ing CVD/CBVD[43]. The largest non-European migrant
groups are from China and South Asia, and these groups
show lower all-cause mortality rates among both men and
women. However, South Asian immigrant women have
the highest rate of IHD among Canadian women[19,44].
Studies from the United States show increased rates of
IHD among Black women [45-47]. Canadian data
indicate that 7.3% of Black women versus 2.8% of Black
men have self-reported CVD, as compared with 3.5% and
3.9% for the entire population respectively[14].
Social Support/Family Structure
Social support plays an important role in an individual's
ability to maintain a healthy lifestyle and recover from ill-
ness and surgery [48-51]. This may be a greater problem
for women, many of whom are widowed or isolated[52].
For instance, 6.8% of Canadian men with self-reported
CVD versus 3.9% of women are married, and 15.6% of
men with self-reported CVD versus 16.5% of women are
widowed[14]. Moreover, women with self-reported CVD
are more often living on their own (9.7%), whereas men
are most frequently living with a partner (11.5%)[14].
These differences in risk factors likely arise from the age-
distribution shift in women's CVD.
Associations between Risk Factors and Self-Reported Heart Disease 
by Sex
Data from the 2000 CCHS concerning risk factors and vul-
nerable subgroups were used to examine self-reported
heart disease in women and men in a multivariate logistic
regression (Some caveats to the use of a cross-sectional
survey like the CCHS should be noted. Risk factors such as
current daily smoking and current heavy alcohol con-
sumption tend to figure odds ratios that suggest they are
protective for heart disease. This is because of a survey bias
stemming from the fact that many people engage in these
behaviours and do not quit until some related disease has
been diagnosed. Their current smoking and drinking are
truly associated with lack of a diagnosis. Questions in the
NPHS/CCHS surveys are not written in such a way that
responses can be used to definitively characterize long-
term levels of smoking and drinking. For instance, it is not
possible to calculate pack years of smoking from the
CCHS data. The two variables "former daily smoker" and
"ever reduced alcohol consumption for any reason" are
surrogates for past heavy drinking and smoking. They are
biased towards a probability of a current diagnosis of
heart disease, since many people quit their habits on the
advice of a clinician. There is a problem with using a self-
reported heart disease outcome, particularly in elderly
people, among whom it is by far more common and is
greatly under-reported, especially in lower education
groups. Caution is warranted when analyzing prevalent
cases of coronary heart or other frequently fatal diseases,
given that the very high initial mortality may result in the
overrepresentation among prevalent cases of people pro-
tected from a poor prognosis). (see Figure 6). For both
sexes, increasing age, lower household income, former
daily smoking, and BMI of less than 27 all showed a pos-
itive risk for heart disease, and being physically active and
having a higher educational level were protective. How-
ever, although being married appears to be protective for
females it is neither protective nor a risk for males. This is
in line with data presented elsewhere showing that family





Physical activity reduces CVD rates of morbidity and mor-
tality among women[53]. The Canadian Heart Health
Survey reported that 36% of Canadian women aged 18 to
74 were classified as physically inactive based on their
self-report of leisure-time physical activities. In the 1998–
1999 NPHS, 53% of Canadian adults were classified as
physically inactive, and this was more prevalent among
Canadian women (56.9%) than men (48.6%)[14], in
populations with lower SES, and with increasing age[54]
(please also refer to the "Personal Health Practices" chap-
ter in this report).
Smoking
Cigarette smoking is the main preventable CVD risk factor
for women and men. It is a stronger risk factor for AMI in
middle-aged women than in men, and in women who use
oral contraceptives[21]. In 1998–1999, more men than
women were daily smokers in all age groups except the
under 24 group (21% of women versus 20% of men)[14].
For instance, daily smoking between the ages of 25 and 39
was reported by 30% of men and 28% of women,
between the ages of 40 and 54 by 28% of men and 24%
of women, and for those aged 55 and over by 18% of men
and 13% of women. Smoking rates tend to be higher in
Quebec and the Atlantic provinces than in other CanadianBMC Women's Health 2004, 4:S15 http://www.biomedcentral.com/1472-6874/4/S1/S15
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provinces (please also refer to the "Sex And Gender Differ-
ences in Smoking and Self Reported Indicators of Health
in Canadian Women" chapter of this report).
Overweight/Obesity
Obesity is highly prevalent among Canadians, and nota-
ble increases across North America have been the trend.
The Canadian Heart Health Survey[17] reported that 41%
of Canadian women aged 18 to 74 years were overweight
(defined as a BMI of > 25 kg/m2), and 27% were obese
(defined as a BMI > 27 kg/m2). The prevalence of obesity
was shown to increase steadily with age and to be higher
among men than women (please also refer to the "Physi-
cal Activity and Obesity in Canadian Women" chapter of
this report).
Interventions Aimed at Women
Prevention
Mortality from CVD and CBVD among Canadian women
has generally declined over the past three to four dec-
ades[3]. However, given that reduced mortality has been
seen to a greater degree among men and those of north-
western European ancestry, we must do more. Unfortu-
nately, there are currently no representative Canadian
data concerning the efficacy of primary or secondary CVD
prevention programs.
North American data generally show significant sex differ-
ences in referral to and participation in secondary preven-
tion programs such as cardiac rehabilitation (CR) [55-60].
In general, 20% fewer women are enrolled in CR than
Bootstrapped Logistic Regression Analysis for Variables Associated With Self-Reported Heart Disease in Canadian Females  and Males Figure 6
Bootstrapped Logistic Regression Analysis for Variables Associated With Self-Reported Heart Disease in 
Canadian Females and Males. The odds ratio estimates and their associated confidence intervals were calculated using the 
Statistics Canada bootstrap weights for the CCHS and the SAS macro program, which was written for that purpose. ‡ Black 
and South Asian ethnic status show odds ratios in the direction of a protective effect for both sexes, but the confidence inter-
vals suggest that these are not statistically robust results. This could be because of a lack of statistical power. Despite the 
130,000 respondent records in the CCHS, there are relatively few people represented with these ethnic backgrounds who 
report currently living with heart disease. Source: 2000 Canadian Community Health Survey (Statistics Canada) (This analysis is 
based on the Statistics Canada CCHS, Cycle 1.1, 2000. All computations on these data were done by Health Canada and the 
responsibility for the use and interpretation of these data is entirely that of authors.)BMC Women's Health 2004, 4:S15 http://www.biomedcentral.com/1472-6874/4/S1/S15
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men,[61,62] a proportion significantly lower than
expected on the basis of morbidity[63]. Despite women's
lower participation[64,65], women of all ages benefit
from CR [66-69], with improvements in functional
capacity, coronary risk and psychosocial well-being that
are comparable with or exceed those of men[66].
Diagnosis/Detection Programs
A gap exists in Canadian CVD surveillance data with
regard to diagnosis and detection programs. Data from
the Canadian Heart Health Survey (1986–1992) show
that risk factors for CVD are under-diagnosed and under-
detected. For instance, only 42% of Canadians with
hypertension were aware that they had hypertension[22].
Of those aged 18 to 74, 26% of men and 18% of women
were hypertensive. Among men, 47% were unaware of
their hypertensive state, for 21% the condition was not
treated and was uncontrolled, for 19% it was treated but
not controlled, and for 13% it was treated and under con-
trol. Among women, 35% were unaware of their hyper-
tensive status, for 15% it was not treated and was
uncontrolled, for 29% it was treated but not controlled,
and for 20% it was treated and under control[70].
Treatment/Interventions
Canadian female AMI patients in every age group are less
likely to undergo either percutaneous transluminal coro-
nary angioplasty (PTCA) or coronary artery bypass graft-
ing (CABG) revascularization[1,71]. This may be partially
explained by women's higher age at CVD onset, given that
the best candidates for revascularization are younger indi-
viduals without comorbid conditions.
Discussion
Data Limitations
To improve our understanding and management of CVD
among women, we must examine surveillance capabili-
ties, research methodologies, and heart health policies
and services (see also the gaps identified in the bulleted
points below). With regard to the surveillance of the diag-
nosis and detection of CVD, we urgently need incidence
estimators at the population level (such as the MONICA/
ICONS project in Nova Scotia). We lack data on recent
physical measures (i.e. hypertension, lipid profiles), for
which self-reporting is notoriously poor. We need recent
data on who is undergoing treatment for hypertension,
hyperlipidemia and depression, and the effectiveness of
these treatments. We are unable to capture the number of
women or men undergoing stress tests, angiography,
echocardiography or 24-hour blood pressure monitoring.
Information on risk factor incidence and prevalence
across the lifespan is also lacking. Methodologically
speaking, person-oriented data for women (and men)
would enable us to follow Canadians longitudinally
through the health care system and across the lifespan.
Surveillance data regarding health services evaluation are
lacking. We are unable to determine the prevalence of
medication prescription, compliance with treatment, or
prevention of CVD and CBVD. Physician service utiliza-
tion data for CVD/CBVD (as compared with those with-
out CVD/CBVD), patient access to physician offices for
prevention of CVD/CBVD (i.e. determined through physi-
cian billing data at the provincial level), and hospitaliza-
tion data for patients with CVD/CBVD versus those
without it are deficient. In short, the following gaps are
notable:
• incidence indicators at the population level;
• recent data on physical measures, such as hypertension
and lipid profile;
• information on people undergoing treatment for hyper-
tension and hyperlipidemia, and the control rate;
• person-oriented data to follow people through the
health care system;
• prevalence of prevention and detection programs,
including community heart health and smoking cessation
programs;
• national drug data for the treatment and prevention of
CVD/CBVD;
• the changing prevalence of congestive heart failure; and
• the number of women and men undergoing stress tests,
angiograms, echocardiography and holteronitoring.
Policy Considerations
With regard to healthy public policy, CVD needs to be rec-
ognized as a women's health issue, given the Canadian
mortality projections, the aging population, and rampant
inequities in health care access and provision. Health pro-
fessionals should be trained to screen and address CVD
risk factors in women, such as hypertension, elevated lipid
levels, smoking, physical inactivity, depression, diabetes
mellitus and low SES. We need to continue developing
and evaluating educational resources for women across
the lifespan regarding their risk for CVD and symptom
presentation. Efforts to encourage healthy eating habits
and physical activity through a multiplicity of approaches
should be pursued. This may include working with local
governments, workplaces, health care providers and the
media to promote the importance of physical activity
while recognizing the unique circumstances of womenBMC Women's Health 2004, 4:S15 http://www.biomedcentral.com/1472-6874/4/S1/S15
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and girls (e.g. by providing a safe environment). Finally,
attention must be paid to barriers to physical activity
among women of diverse ethnocultural backgrounds and
social classes.
Notes
The views expressed in this report do not necessarily rep-
resent the views of the Canadian Population Health
Initiative, the Canadian Institute for Health Information
or Health Canada.
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